Clinical Trials Sponsored by EMN Research Italy

Total 389 results

EMN Research Italy

Active, not recruiting

A Trial for Relapsed Multiple Myeloma Patients (Isatuximab-dexamethasone) (ISABEL)

Relapsed Multiple Myeloma

Italy
European Myeloma Network
EMN Research Italy

Active, not recruiting

Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara

Multiple Myeloma

Czechia, Greece, Italy
Fondazione EMN Italy Onlus

Recruiting

Patient With MMRR Treated With Belantamab Mafotidine on Monotherapy

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Completed

Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma Patients (RP_MPR)

Multiple Myeloma
Fondazione EMN Italy Onlus

Completed

Velcade, Melphalan, Prednisone And Thalidomide Versus Velcade, Melphalan, Prednisone in Multiple Myeloma Patients

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Active, not recruiting

A Trial for Relapsed and Relapsed/Refractory Multiple Myeloma Patients (DPd)

Multiple Myeloma | Deletion 17P Syndrome

Italy
Fondazione EMN Italy Onlus

Completed

Monitoring of Deep of Response During Lenalidomide Maintenance in MM Patients Achieving at Least Very Good Partial Response (MRD) (MRD)

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Completed

Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Recruiting

A "Physician & Patient-powered" Cohort Registry (MY MYELOMA) (MY MYELOMA)

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Completed

Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation (TLI)

HEMATOLOGIC MALIGNANCIES

Italy
Fondazione EMN Italy Onlus

Completed

Detection of Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Active, not recruiting

A Trial That Compare Two Treatments in Newly Diagnosed Myeloma Patients Not Eligible for Transplant (KRdvsRd)

Multiple Myeloma | New Diagnosis Tumor

Italy
Fondazione EMN Italy Onlus

Active, not recruiting

Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma Subjects

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Completed

Pomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma (MM) Relapsed and/or Refractory to Lenalidomide (PCP)

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Completed

RMPT for Relapsed/Refractory Multiple Myeloma (RMPT)

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Terminated

Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients (D-MP)

Myeloma

Italy
Fondazione EMN Italy Onlus

Active, not recruiting

Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Active, not recruiting

Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients (MPRvsMEL200)

Multiple Myeloma | Newly Diagnosed Patients

Italy
Fondazione EMN Italy Onlus

Active, not recruiting

STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Completed

Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Terminated

Pom-dex Versus Pom-Cyclo-dex in MM Patients With Biochemical or Clinical Relapse, During Lena Maintenance Treatment (PO-3887)

Multiple Myeloma

Italy
European Myeloma Network
Sanofi; Amgen; EMN Research Italy

Active, not recruiting

Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL) (IsKia)

Multiple Myeloma

Czechia, Germany, Greece, Italy, Netherlands, Norway, Spain
European Myeloma Network
Fondazione EMN Italy Onlus

Completed

Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CCD)

Multiple Myeloma

Italy
European Myeloma Network
Fondazione EMN Italy Onlus

Completed

Maintenance Therapy With Subcutaneous Bortezomib

Multiple Myeloma

Italy
European Myeloma Network
Fondazione EMN Italy Onlus

Completed

Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (CCD)

Multiple Myeloma

Netherlands, Italy
European Myeloma Network
Fondazione EMN Italy Onlus

Completed

Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone

Multiple Myeloma

Italy
Stichting European Myeloma Network
Fondazione EMN Italy Onlus

Completed

COVID-19 Infection and Multiple Myeloma (EMN-COVID)

Covid19 | Multiple Myeloma | Corona Virus Infection

Czechia, Netherlands, United Kingdom, Belgium, Germany, Austria, Greece, Italy
Stichting European Myeloma Network
Fondazione EMN Italy Onlus

Completed

Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple Myeloma

Multiple Myeloma

Germany, Italy
Stichting European Myeloma Network
Fondazione EMN Italy Onlus

Active, not recruiting

Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd) (wCCyd)

Multiple Myeloma

Italy
Cancer Prevention and Research Institute, Italy
Ministry of Health, Italy

Unknown

Tailored Screening for Breast Cancer in Premenopausal Women (TBST)

Breast Cancer

Italy
Cancer Prevention and Research Institute, Italy

Unknown

Innovation in Mammography: Tomosynthesis Pathways (IMPETO)

Breast Cancer

Italy
MD Italy
Hippocrates Research; Nubilaria Srl

Completed

Study on Safety and Performance of an Artificial Tear in Dry Eye Treatment in Subjects With Ocular Surface Inflammation

Dry Eye Disease

Italy
Stichting European Myeloma Network
Celgene Corporation; Healt Data Specialists - HeaDS (CRO); EMN Research Italy...

Active, not recruiting

Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients

Multiple Myeloma

France, Greece, Italy, Netherlands
Bambino Gesù Hospital and Research Institute
Ministry of Health, Italy; Parent Project, Italy

Unknown

Ventricular Remodelling and Metabolomics in Pediatric Cardiomyopathies (PROGRESS-OMICS) (PRO-OMICS)

Cardiomyopathies | Pediatric ALL

Italy
Cancer Prevention and Research Institute, Italy
Veneto Tumor Registry, Azienda Zero, Padua, Italy

Unknown

Adenoma Detection Rate With Endocuff-Assisted Colonoscopy - an Italian Trial (ITAvision)

Colorectal Neoplasms | Colorectal Cancer | Colorectal Adenoma | Colorectal Polyp

Italy
University of Turin, Italy
Research Center Borstel

Unknown

Personalization of AntiTB Treatment: Evaluation of Pharmacological Determinants of Treatment Response (PAT)

Tuberculosis, Pulmonary

Italy
Fondazione C.N.R./Regione Toscana "G. Monasterio...
Ministry of Education, Universities and Research, Italy

Unknown

Genetic Mapping for Cardiac Risk Assessment (GENOCOR)

Myocardial Infarction | Myocardial Ischemia | Coronary Disease | Angina Pectoris | Acute Coronary Syndrome

Italy
University of Palermo
National Research Council of Italy

Not yet recruiting

Tolerability of an Ancient Grain in Patients With Non-Celiac Wheat Sensitivity

Non-celiac Gluten Sensitivity

Italy
IRCCS Eugenio Medea
National Research Council of Italy

Unknown

Functional and MRI Evaluation of the Robot-assisted and Traditional Rehabilitation Programs on the Muscle

Traumatic Brain Injury

Italy
Mario Negri Institute for Pharmacological Research
Bio3 Research s.r.l. - Milan Italy

Completed

L-Cysteine in Peritoneal Dialysis (CINDY)

Uremia

Italy
Cancer Prevention and Research Institute, Italy
University of Florence

Completed

Screening for Colorectal Cancer With FOBT, Virtual Colonoscopy and Optical Colonoscopy. A Randomized Clinical Trial in the Florence District (SAVE)

Colorectal Cancer

Italy
Cancer Prevention and Research Institute, Italy
Istituto Toscano Tumori

Unknown

Self Collected Sampling in Non-attendees Cervical Cancer Screening: DNA Test and Molecular Triage for HPV Positive Women

Cervical Cancer

Italy
Villa Beretta Rehabilitation Center
National Research Council of Italy

Completed

Rehabilitation Multi Sensory Room for Robot Assisted Functional Movements in Upper-limb Rehabilitation in Chronic Stroke (RehaMSR)

Chronic Stroke

Italy
EMD Serono Research & Development Institute, Inc.

Recruiting

The MS-LINK™ Outcomes Study

Multiple Sclerosis

United States
EMD Serono Research & Development Institute, Inc.

Completed

Oral Cladribine in Early Multiple Sclerosis (MS) (ORACLE MS)

Multiple Sclerosis

Lebanon, United States, Turkey, Sweden, Finland, France, Thailand, Serbia, Italy, United Kingdom, United Arab Emirates, Bulgaria, Belgium, Estonia, Argentina, Austria, Bosnia and Herzegovina, Canada, Croatia, Czechia, Georgia, Ger... and more
IRCCS Eugenio Medea
Regione Lombardia; National Research Council of Italy

Completed

Experimentation of an Ankle Mobilization Device for the Rehabilitation of Patients With Acquired Brain Injuries.

Acquired Brain Injury

Italy
Center for Outcomes Research and Clinical Epidemiology...
Artsana S.p.a.

Unknown

Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. (AGO 02)

Diabetes Mellitus

Italy
EMD Serono Research & Development Institute, Inc.

Recruiting

Next-Gen MS: Feed-forward PRO Data for MS Research

Multiple Sclerosis (MS)

United States
EMD Serono Research & Development Institute, Inc.

Completed

Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)

Carcinoma, Merkel Cell

United States, Spain, Australia, Italy, Germany, France, Japan
EMD Serono Research & Development Institute, Inc.

Completed

CLARITY Extension Study

Relapsing-Remitting Multiple Sclerosis

Croatia, United States, Bulgaria, France, Italy, Russian Federation, Turkey, United Kingdom, Estonia, Germany, Latvia, Lithuania, Poland, Austria, Brazil, Canada, Finland, Portugal, Greece, Serbia, Denmark, Ukraine, Saudi Arabia, Lebanon and more

Clinical Trials Sponsored by EMN Research Italy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations